We are live on ! Find out more
LMNL

Liminal BioSciences Inc. Common Shares
LMNL

Delisted

LMNL was delisted on the 25th of September, 2023.

Back to rankings

8 hedge funds and large institutions have $108K invested in Liminal BioSciences Inc. Common Shares in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

3% more capital invested

Capital invested by funds: $105K → $108K (+$3.05K)

0% more funds holding

Funds holding: 8 → 8 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$11.3K
2
UBS Group
UBS Group
Switzerland
+$4.42K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$3.56K
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
+$384

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$53.7K
2
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$7
Name Holding Trade Value Shares
Change 		Change in
Stake
National Bank of Canada
1
National Bank of Canada
Quebec, Canada
$61.1K -$7 -1 -0%
FDCDDQ
2
Federation des caisses Desjardins du Quebec
Quebec, Canada
$21.2K +$384 +58 +2%
Morgan Stanley
3
Morgan Stanley
New York
$10.7K +$11.3K +1,706 New
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$7K +$3.56K +537 +107%
UBS Group
5
UBS Group
Switzerland
$4.49K +$4.42K +667 +1,390%
ECM
6
Estabrook Capital Management
New York
$3.14K – – –
TWC
7
TD Waterhouse Canada
Ontario, Canada
$25 – – –
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
– -$53.7K -14,133 Closed

LMNL Hedge Fund Activity: Q2 2023 in Review

8 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q2 2023, worth a combined $108K — up 2.9% from $105K a quarter earlier.

Fund positioning in LMNL was balanced in Q2 2023: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $11.3K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $53.7K sold.

  • 8 institutional investors held Liminal BioSciences Inc. Common Shares (LMNL) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $108K of Liminal BioSciences Inc. Common Shares stock for Q2 2023, up 2.9% quarter-over-quarter.
  • 1 fund opened new Liminal BioSciences Inc. Common Shares positions in Q2 2023 and 1 closed out, a net change of 0 holders.
  • The largest Liminal BioSciences Inc. Common Shares buyer in Q2 2023 was Morgan Stanley, an estimated $11.3K added.
  • The largest Liminal BioSciences Inc. Common Shares seller in Q2 2023 was Susquehanna International Group, an estimated $53.7K sold.

Based on aggregated 13F filings for Q2 2023.